Incidence and mortality rates of lip, oral cavity, and pharynx cancers in Brazil: time-trend and age-period-cohort analysis from the last 30 years, Global Burden of Disease Study.


Journal

Revista da Sociedade Brasileira de Medicina Tropical
ISSN: 1678-9849
Titre abrégé: Rev Soc Bras Med Trop
Pays: Brazil
ID NLM: 7507456

Informations de publication

Date de publication:
2022
Historique:
received: 05 05 2021
accepted: 12 07 2021
entrez: 2 2 2022
pubmed: 3 2 2022
medline: 5 2 2022
Statut: epublish

Résumé

Cancers are the second main cause of morbidity worldwide, but robust information on lip, oral cavity, and pharynx cancers in Brazil is lacking. This study aimed to analyze the trends of incidence and mortality caused by lip, oral cavity, and pharynx cancers and age-period-cohort effects in the Brazilian population of 30 years of age and over, in the period of 1990 to 2019. A time series study of the incidence and mortality rates for oral cavity and pharynx cancer ("Lip and oral cavity cancer", "Nasopharynx cancer", and "Other pharynx cancer") was conducted, with corrected data from the Global Burden of Disease Study (GBD) 2019. Age-standardized rates per 100,000 inhabitants, for the global population, were gathered according to the individuals' sex. The annual average percentage change (AAPC) was estimated, as was the age-period-cohort effects. The incidence and mortality rates were higher for men in the studied anatomical regions. The cancers tended to decrease for men, except for nasopharynx cancer, which increased in individuals of both sexes. Mortality tended to present a decline in most of the groups studied. For men and women, the age-period-cohort model presented a better adjustment for both incidence and mortality. Incidence and mortality caused by the main head and neck cancers showed a tendency to decline over the past 30 years in Brazil, except for nasopharynx cancer, which showed an increase in incidence and mortality in some segments of the population. Higher rates were found for lip and oral cavity cancers in men.

Identifiants

pubmed: 35107536
pii: S0037-86822022000500316
doi: 10.1590/0037-8682-0286-2021
pmc: PMC9009427
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0286

Références

BMC Cancer. 2019 Oct 11;19(1):940
pubmed: 31604464
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):16-27
pubmed: 26667886
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Cad Saude Publica. 2017 Aug 07;33(7):e00104516
pubmed: 28792992
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Asia Pac J Clin Oncol. 2018 Feb;14(1):16-22
pubmed: 28816028
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
pubmed: 15734974
Cancer Commun (Lond). 2020 Mar;40(2-3):81-92
pubmed: 32067418
J Bras Pneumol. 2011 Jan-Feb;37(1):118-28
pubmed: 21390440
Cad Saude Publica. 2018 Jun 25;34(6):e00077617
pubmed: 29952399
Cancer Epidemiol. 2016 Sep;44 Suppl 1:S43-S52
pubmed: 27678322
Cell Death Dis. 2019 Jul 15;10(8):540
pubmed: 31308358
Cien Saude Colet. 2014 Apr;19(4):1263-74
pubmed: 24820609
Cad Saude Publica. 2019 Nov 28;35(12):e00014319
pubmed: 31800779
Surg Oncol Clin N Am. 2015 Jul;24(3):379-96
pubmed: 25979389
PLoS One. 2020 Feb 21;15(2):e0229154
pubmed: 32084177
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Annu Rev Public Health. 1991;12:425-57
pubmed: 2049144
BMC Oral Health. 2021 Jan 28;21(1):44
pubmed: 33509185
Oral Dis. 2022 Jan;28(1):97-107
pubmed: 33215764
Popul Health Metr. 2020 Sep 30;18(Suppl 1):20
pubmed: 32993689
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
Braz J Otorhinolaryngol. 2016 Mar-Apr;82(2):140-3
pubmed: 26631328
Clin Epidemiol. 2021 Feb 24;13:149-159
pubmed: 33658861
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
J Dent Res. 2020 Feb;99(2):143-151
pubmed: 31874128
Epidemiol Serv Saude. 2016 Oct-Dec;25(4):777-787
pubmed: 27869971
Nat Med. 2021 Feb;27(2):239-243
pubmed: 33479500
Cad Saude Publica. 2014 Aug;30(8):1721-30
pubmed: 25210911
Head Neck Pathol. 2020 Dec;14(4):899-908
pubmed: 32077056
Bull World Health Organ. 2007 Jul;85(7):527-34
pubmed: 17768501
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326

Auteurs

Daniel Volpato Romagna (DV)

Universidade do Sul de Santa Catarina, Faculdade de Medicina, Tubarão, SC, Brasil.

Max Moura de Oliveira (MM)

Universidade Federal de Goiás, Instituto de Patologia Tropical e Saúde Pública, Departamento de Saúde Coletiva, Goiânia, GO, Brasil.

Lucas Guimarães Abreu (LG)

Universidade Federal de Minas Gerais, Faculdade de Odontologia, Belo Horizonte, MG, Brasil.

Caroline Stein (C)

Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Epidemiologia, Porto Alegre, RS, Brasil.

Fernando Neves Hugo (FN)

Universidade Federal do Rio Grande do Sul, Departamento de Odontologia Preventiva e Social, Porto Alegre, RS, Brasil.

Renato Teixeira (R)

Universidade Federal de Minas Gerais. Belo Horizonte, MG, Brasil.

Deborah Carvalho Malta (DC)

Universidade Federal de Minas Gerais. Belo Horizonte, MG, Brasil.

Mohsen Naghavi (M)

University of Washington, Institute for Health Metrics and Evaluation, Seattle, WA, United States.

Betine Pinto Moehlecke Iser (BPM)

Universidade do Sul de Santa Catarina, Programa de Pós-Graduação em Ciências da Saúde, Tubarão, SC, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH